CCME Global (BSE 514336)₹39.27+0.87%Biotechnology
In the Mar 2026 quarter (standalone), CCME Global reported sales of ₹0.05 Cr and net profit of −₹0.51 Cr. For the year to Mar 2026, sales were ₹0.05 Cr and net profit −₹0.72 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| Expenses | 0.05 | 0.01 | 0.01 | 3.67 | 0.09 | 0.01 | 0.02 | 0.01 | 0.11 | 0.05 | 0.02 | 0.53 |
| Operating Profit | −0.05 | −0.01 | −0.01 | −3.68 | −0.09 | 3.64 | −0.02 | −0.01 | −0.11 | −0.05 | −0.02 | −0.49 |
| OPM % | — | — | — | — | — | 99.5% | — | — | — | — | — | −1,250.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.07 | −0.03 | −0.03 | −3.70 | −0.11 | 3.66 | −0.04 | −0.03 | −0.13 | −0.07 | −0.04 | −0.51 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.07 | −0.03 | −0.03 | −3.70 | −0.11 | 3.66 | −0.04 | −0.03 | −0.13 | −0.07 | −0.04 | −0.51 |
| EPS (Rs) | −0.06 | −0.03 | −0.03 | −2.85 | −0.09 | 2.82 | −0.03 | −0.03 | −0.10 | −0.06 | −0.03 | −0.12 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.30 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 |
| Expenses | 0.06 | 0.06 | 0.48 | 0.09 | 0.09 | 0.11 | 0.11 | 0.13 | 3.78 | 0.16 | 0.74 | 0.71 |
| Operating Profit | −0.06 | −0.06 | −0.19 | −0.04 | −0.09 | −0.11 | −0.11 | −0.13 | −3.79 | −0.16 | −0.70 | −0.67 |
| OPM % | — | — | −69.0% | −100.0% | — | — | — | — | — | 95.4% | −1,775.0% | −1,340.0% |
| Other Income | 0.41 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.66 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.36 | 0.00 | −0.21 | −0.06 | −0.11 | −0.13 | −0.13 | −0.15 | −3.81 | 3.51 | −0.72 | −0.75 |
| Tax % | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.36 | 0.00 | −0.21 | −0.06 | −0.11 | −0.13 | −0.13 | −0.15 | −3.81 | 3.51 | −0.72 | −0.75 |
| EPS (Rs) | 0.37 | 0.00 | −0.16 | −0.05 | −0.09 | −0.10 | −0.10 | −0.12 | −2.93 | 2.70 | −0.17 | −0.31 |
| Dividend payout % | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.11 | 9.72 | 9.98 | 12.98 | 12.97 | 12.97 | 12.97 | 12.98 | 12.98 | 12.99 | 12.99 | 45.16 |
| Reserves | −3.72 | −3.36 | −3.36 | −3.56 | −3.71 | −3.81 | −3.93 | −4.06 | −4.18 | −7.98 | −4.49 | −5.20 |
| Borrowings | 0.18 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.94 | 0.51 | 0.04 | 0.07 | 0.09 | 0.13 | 0.13 | 0.14 | 0.14 | 0.19 | 0.31 | 5.21 |
| Total Liabilities | 4.51 | 7.08 | 6.66 | 9.49 | 9.35 | 9.29 | 9.17 | 9.06 | 8.94 | 5.20 | 8.81 | 45.17 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 4.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.51 | 7.08 | 6.66 | 4.84 | 9.35 | 9.29 | 9.17 | 9.06 | 8.94 | 5.20 | 8.81 | 45.17 |
| Trade receivables | 0.48 | 0.48 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & equivalents | 0.03 | 0.00 | 0.02 | 0.04 | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 37.47 |
| Total Assets | 4.51 | 7.08 | 6.66 | 9.49 | 9.35 | 9.29 | 9.17 | 9.06 | 8.94 | 5.20 | 8.81 | 45.17 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −4.88 | −2.65 | −0.26 | 1.69 | −4.71 | 0.02 | −0.13 | −0.13 | −0.10 | 5.11 |
| Cash from investing activity | 0.76 | 0.00 | 0.00 | −4.65 | 4.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing activity | 4.11 | 2.63 | 0.27 | 3.01 | 0.00 | 0.00 | 0.13 | 0.13 | 0.10 | 32.37 |
| Net cash flow | 0.00 | −0.01 | 0.00 | 0.01 | −0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 37.25 |
| Free cash flow | −4.10 | −2.65 | −0.26 | 1.69 | −4.70 | 0.02 | −0.13 | −0.13 | −0.10 | 5.11 |
| CFO / OP % | 3,240.0% | 3,771.0% | 357.0% | −840.0% | 9,380.0% | −10.0% | 100.0% | 100.0% | 64.0% | −718.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 228 | — | — | 62 | 291 | — | — | — | — | — | — | 0 |
| Inventory days | 0 | — | — | 0 | — | — | — | — | — | — | — | — |
| Cash conversion cycle | 229 | — | — | 63 | 292 | — | — | — | — | — | — | 0 |
| Working capital days | 1,587 | — | — | 5,992 | 67,891 | — | — | — | — | — | — | 24,730 |
| ROCE % | −16.6% | 6.9% | 0.0% | −2.5% | −0.5% | −1.1% | −1.3% | −1.3% | −1.6% | −54.8% | 51.7% | −2.9% |
For the Mar 2026 quarter, CCME Global reported sales of ₹0.05 Cr and net profit of −₹0.51 Cr. The operating margin was −1,250.0%.
CCME Global's sales for the year to Mar 2026 were ₹0.05 Cr; over the last twelve months they were ₹0.05 Cr.
Net profit for the year to Mar 2026 was −₹0.72 Cr, and −₹0.75 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.31.
CCME Global reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹37.47 Cr.
Cash from operations was ₹5.11 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.11 Cr.